Profit Investment Management, LLC Amgen Inc Transaction History

Profit Investment Management, LLC

$160 Million
Q2 2024

A detailed history of Profit Investment Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Profit Investment Management, LLC holds 3,450 shares of AMGN stock, worth $1.1 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

3,450

Previous 3,369 2.4%

Holding current value

$1.1 Million

Previous $957,000 12.54%

% of portfolio

0.67%

Previous 0.54%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	BUY	$262.75 - $319.31 $21,282 - $25,864	81 Added 2.4%	3,450 $1.08 Million
Q1 2024 Apr 11, 2024	SELL	$268.87 - $324.56 $7,797 - $9,412	-29 Reduced 0.85%	3,369 $957,000
Q3 2023 Oct 05, 2023	SELL	$218.65 - $271.46 $25,800 - $32,032	-118 Reduced 3.36%	3,398 $913,000
Q2 2023 Jul 10, 2023	SELL	$214.27 - $253.37 $8,785 - $10,388	-41 Reduced 1.15%	3,516 $780,000
Q1 2022 Apr 20, 2022	BUY	$219.27 - $242.57 $41,880 - $46,330	191 Added 5.67%	3,557 $859,000
Q4 2021 Jan 19, 2022	SELL	$198.88 - $227.6 $31,621 - $36,188	-159 Reduced 4.51%	3,366 $756,000
Q4 2020 Jan 20, 2021	SELL	$216.38 - $257.67 $1.2 Million - $1.43 Million	-5,546 Reduced 61.14%	3,525 $811,000
Q3 2020 Nov 09, 2020	BUY	$234.65 - $260.95 $10,089 - $11,220	43 Added 0.48%	9,071 $2.31 Million
Q2 2020 Jul 16, 2020	BUY	$197.81 - $242.74 $117,696 - $144,430	595 Added 7.06%	9,028 $2.13 Million
Q1 2020 Apr 23, 2020	BUY	$182.24 - $241.7 $513,734 - $681,352	2,819 Added 50.21%	8,433 $1.71 Million
Q1 2018 Apr 10, 2018	SELL	$169.43 - $198.0 $168,582 - $197,010	-995 Reduced 15.06%	5,614 $957,000
Q3 2017 Oct 18, 2017	BUY	$167.29 - $191.0 $1.11 Million - $1.26 Million	6,609	6,609 $1.23 Million

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profit Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profit Investment Management, LLC with notifications on news.

Account

Profit Investment Management, LLC Amgen Inc Transaction History